Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Colony Biotechnology is a prominent life sciences company based in Guangzhou, China, specializing in the research, development, and large-scale production of food additives and ingredients through biological fermentation. The company is recognized as a leading global manufacturer of Sucralose, a high-intensity sweetener used extensively in the food, beverage, and pharmaceutical industries as a zero-calorie sugar substitute. In addition to sweeteners, Guangzhou Colony Biotechnology produces natural food colorants, including Monascus Red and Monascus Yellow, which are derived from traditional fermentation processes. Headquartered in the Panyu District, the company operates advanced manufacturing facilities that comply with international quality standards such as ISO, HACCP, and GMP. As a National High-tech Enterprise, it serves a diverse global clientele, providing essential ingredients and excipients for various health and nutrition applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Colony Biotechnology.